Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Magnani

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Nature Genetics|January 24, 2017
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancerLuca Magnani, Gianmaria Frige, Raffaella Maria Gadaleta, et al.
Nature Communications|November 28, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
ACS Nano|January 28, 2016
Spearhead Nanometric Field-Effect Transistor Sensors for Single-Cell AnalysisYanjun Zhang, Jan Clausmeyer, Babak Babakinejad, et al.
Nature Communications|May 12, 2018
TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionSilvia Ottaviani, Justin Stebbing, Adam E Frampton, et al.
Nature Communications|August 8, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Medicine|July 25, 2018
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancerDarren K Patten, Giacomo Corleone, Balázs Győrffy, et al.
Nature Communications|August 16, 2019
Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionSilvia Ottaviani, Justin Stebbing, Adam E Frampton, et al.
Minerva Medica|February 8, 2021
Long-term methotrexate use in rheumatoid arthritis patients: real-world data from the MARTE studyTeodora Serban, Roberto Allara, Valeria Azzolini, et al.
Cancer Discovery|December 4, 2023
Cancer Evolution: A Multifaceted AffairGiovanni Ciriello, Luca Magnani, Sarah J Aitken, et al.
Cancer Research|June 11, 2025
Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype ParadigmErica A Oliveira, Salvatore Milite, Javier Fernandez-Mateos, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Nature Genetics|January 24, 2017
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancerLuca Magnani, Gianmaria Frige, Raffaella Maria Gadaleta, et al.
Nature Communications|November 28, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
ACS Nano|January 28, 2016
Spearhead Nanometric Field-Effect Transistor Sensors for Single-Cell AnalysisYanjun Zhang, Jan Clausmeyer, Babak Babakinejad, et al.
Nature Communications|May 12, 2018
TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionSilvia Ottaviani, Justin Stebbing, Adam E Frampton, et al.
Nature Communications|August 8, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Medicine|July 25, 2018
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancerDarren K Patten, Giacomo Corleone, Balázs Győrffy, et al.
Nature Communications|August 16, 2019
Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionSilvia Ottaviani, Justin Stebbing, Adam E Frampton, et al.
Minerva Medica|February 8, 2021
Long-term methotrexate use in rheumatoid arthritis patients: real-world data from the MARTE studyTeodora Serban, Roberto Allara, Valeria Azzolini, et al.
Cancer Discovery|December 4, 2023
Cancer Evolution: A Multifaceted AffairGiovanni Ciriello, Luca Magnani, Sarah J Aitken, et al.
Cancer Research|June 11, 2025
Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype ParadigmErica A Oliveira, Salvatore Milite, Javier Fernandez-Mateos, et al.
Pageof 13